Zoono Group Limited is a Public Company listed on the Australian Stock Exchange (ASX: ZNO), specializing in the development, manufacture and global distribution of a suite of unique, proven, long lasting antibacterial solutions that have a distinct competitive advantage.
Over the past 7 years, Zoono has developed many unique products (together with specific industry application protocols) that enable our customer partners and distributors to realize and maximise revenue producing and commercial opportunities for these products and services.
Zoono Group has also developed (and owns) a wealth of Intellectual Property based around the “Zoono Molecule” – it’s unique antimicrobial that bonds to any surface (including hard surfaces, textiles, fabrics, skin etc) and kills pathogens including bacteria, algae, and mould. Best of all, it has proven efficacy and longevity – it does not leach and cannot diminish in strength.
Today, Zoono Group has established a global network of customers and distributors spread across many countries and territories. As the market leader in its field, Zoono Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.